Mouse mammary stem cells express prognostic markers for triple-negative breast cancer

INTRODUCTION: Triple-negative breast cancer (TNBC) is a heterogeneous group of tumours in which chemotherapy, the current mainstay of systemic treatment, is often initially beneficial but with a high risk of relapse and metastasis. There is currently no means of predicting which TNBC will relapse. W...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Breast Cancer Res
Main Authors: Soady, Kelly J, Kendrick, Howard, Gao, Qiong, Tutt, Andrew, Zvelebil, Marketa, Ordonez, Liliana D, Quist, Jelmar, Tan, David Wei-Min, Isacke, Clare M, Grigoriadis, Anita, Smalley, Matthew J
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2015
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4381533/
https://ncbi.nlm.nih.gov/pubmed/25849541
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13058-015-0539-6
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados